Skip to main content
. Author manuscript; available in PMC: 2023 Aug 19.
Published in final edited form as: Pain. 2023 Mar 30;164(9):1942–1953. doi: 10.1097/j.pain.0000000000002891

Table 1.

Pain prevalence levels and differences by sexual identity

Pain prevalence levels Pain prevalence differences Respondent N and %
Prevalence 95% CI Percentage-point difference1 Relative difference1 Number of respondents2 Weighted percentage2
PANEL A. Pain in 3+ sites
 Straight 11.5 (11.3, 11.7) -- -- 129,426 96.65
 Gay/lesbian 16.1 (14.3, 18.1) 4.6 1.40*** (1.26, 1.56) 2,743 1.86
 Bisexual 20.1 (17.6, 22.8) 8.6 1.75*** (1.53, 1.99) 1,595 1.14
 “Something else” 22.9 (18.2, 28.3) 11.4 1.99*** (1.60, 2.46) 502 0.35
PANEL B. Chronic pain
 Straight 17.2 (16.9, 17.5) -- -- 92,062 96.60
 Gay/lesbian 21.7 (19.3, 24.4) 4.5 1.26*** (1.12, 1.41) 2,006 1.92
 Bisexual 23.7 (20.8, 26.9) 6.5 1.38*** (1.21, 1.56) 1,210 1.14
 “Something else” 27.0 (21.8, 32.9) 9.8 1.57*** (1.28, 1.91) 397 0.35
***

p<.001. N = number of respondents, or sample size

NHIS 2013–2018, US adults age 18–64. N=134,266 for pain in 3+ sites and N=95,675 for chronic pain. Overall weighted prevalence was 11.7% (11.5,11.9) for pain in 3+ sites and 17.4% (17.1,17.7) for chronic pain.

“Something else” was the actual verbatim terminology used on the NHIS survey; it captures other non-heterosexual identified adults. More information about the design of the sexual identity question is available elsewhere [52].

1

Relative to straight respondents. Percentage point difference is just the arithmetic difference in prevalence levels; the relative difference is a prevalence ratio obtained from complex-survey-adjusted (modified/robust) bivariate Poisson model of each outcome as a function of sexual identity.

2

The number of respondents is the raw count of respondents in the sample with valid information, that is, number used in analyses; the weighted percentage corresponds to the distribution of the groups in the population (target population of the NHIS, which is non-institutionalized US adults).